The role of the Coordination Group is to investigate all aspects connected with the authorisation to place a medicinal product on the market in two or more EU member states. Every authorisation to place a medicinal product on the market must answer a wide range of questions involving new applications, amendments, prolongations and pharmacovigilance activities.
The Coordination Group examines conflicts of opinion between member states during the authorisation process. The aim is to guarantee close cooperation between member states which helps avoid any duplication of efforts.
Organiser: Federal Ministry of Health